Page last updated: 2024-11-03

propofol and Rhabdoid Tumor

propofol has been researched along with Rhabdoid Tumor in 1 studies

Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.

Rhabdoid Tumor: A rare but highly lethal childhood tumor found almost exclusively in infants. Histopathologically, it resembles RHABDOMYOSARCOMA but the tumor cells are not of myogenic origin. Although it arises primarily in the kidney, it may be found in other parts of the body. The rhabdoid cytomorphology is believed to be the expression of a very primitive malignant cell. (From Holland et al., Cancer Medicine, 3d ed, p2210)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shukry, M1
Ramadhyani, U1

Other Studies

1 other study available for propofol and Rhabdoid Tumor

ArticleYear
Dexmedetomidine as the primary sedative agent for brain radiation therapy in a 21-month old child.
    Paediatric anaesthesia, 2005, Volume: 15, Issue:3

    Topics: Brain Neoplasms; Dexmedetomidine; Humans; Hypnotics and Sedatives; Infant; Male; Propofol; Radiother

2005